REFERENCES

1. Bonemarrow Pathology, Barbara Bain, 4^th edition
2. The Association Between JAK2V617F Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms.M. Cem Arı,^1,* Deram Büyüktaş,²Turk J Haematol. 2012 Sep; 29(3): 242–247.
3. Bentley, S.A., Alabaster, O. andFoidart, J.M. (1981) Collagen heterogeneity in normal human bone marrow. British Journal of Haematology, 48, 287–291.
4. Bauermeister, D.E. (1971) Quantitation of bone marrow reticulin – a normal range. American Journal of Clinical Pathology, 56, 24–31. Beckman, E.N. and Brown, A.W., (1990)
5. Normal reticulin level in iliac bone marrow. Archives of Pathology and Laboratory Medicine, 114, 1241–1243.
6. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica, 90, 1128–1132.
7. Pereira, R.M., Velloso, E.R., Menezes, Y., Gualandro, S., Vassalo, J. andYoshinari, N.H. (1998) Bone marrow findings in systemic lupus erythematosus patients with peripheral cytopenias. Clinical Rheumatology, 17, 219–222.
8. Thiele, J., Grashof, K. and Fisher, R. (1991) Follow-up study on bone marrow reticulin fibrosis in AML. Analytical Cellular Pathology, 3, 225–231. Thiele, J., Kvasnicka, H.M., Facchetti, F., Franco, V., van der Walt, J. andOrazi, A. (2005)
9. Hann, I.M., Evans, D.I., Marsden, H.B., Jones, P.M. and Palmer, M.K. (1978) Bone marrow fibrosis in acute lymphoblastic leukaemia of childhood. Journal of Clinical Pathology, 31, 313–315.
10. Bass, R.D., Pullarkat, V., Feinstein, D.I., Kaul, A., Winberg, C.D. andBrynes, R.K. (2001) Pathology of autoimmune myelofibrosis. A report of three cases and a review of the literature. American Journal of Clinical Pathology, 116, 211–216.
11. Thiele, J. andKvasnicka, H.M. (2006) Grade of bone marrow fibrosis is associated with relevant hematological findings-a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis. Annals of Hematology, 85, 226–232.
12. Popat, U., Frost, A., Liu, E., May, R., Bag, R., Reddy, V. and Prchal, J.T. (2005) New onset of myelofibrosis in association with pulmonary arterial hypertension. Annals of Internal Medicine, 143, 466–467.
13. Beham-Schmid, C., Apfelbeck, U., Sill, H., Tsybrovsky, O., Hofler, G., Haas, O.A. and Linkesch, W. (2002) Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis. Blood, 99, 381–383.